A case of epithelioid sarcoma in the tongue is reported. The patient, a 35 year old woman, presented with a nonulcerated painful lesion of the tongue. Microscopically, the tumour was characterised by multiple coalescent nodules with central geographic necrosis infiltrating the lingual muscle. The tumour cells were epithelioid with abundant eosinophilic cytoplasm and atypical nuclei. Immunohistochemically, the tumour cells stained for vimentin, keratin, and epithelial membrane antigen. These morphological and immunohistochemical appearances led to the diagnosis of epithelioid sarcoma of the tongue. Seven years later, the patient died with metastatic dissemination to the scalp, lungs, and brain. No case of epithelioid sarcoma arising in the tongue has been described previously. (7 Clin Pathol 1997;5:0869-870) ures per 10 high power fields). No vascular invasion was seen. The lymph node metastases were similar to the primary tumour.
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Immunohistochemically the tumour cells stained for cytokeratin (KL1 diluted 1/120; Immunotech, Marseille, France) (fig 3) , epithelial membrane antigen diluted 1/50 (Dako, Trappe, France), and vimentin diluted 1/200 (Dako) . No staining was seen with antibodies to S-100 protein diluted 1/400 (Dako), cytokeratin 7 The histogenesis of this tumour is uncertain: a pluripotential mesoderm origin is proposed by some authors.9 A relation with extrarenal malignant rhabdoid tumours was also suggested. ' Epithelioid sarcoma is a malignant neoplasm with frequent local recurrences and often metastatic dissemination in regional lymph nodes, in the scalp, lungs, and brain.
Halling et al 1' in a recent review of 55 cases found three histological variables associated with a poor prognosis: vascular invasion, tumour size of more than 5 cm, and more than 30% necrosis.
The treatment is radical surgery with radiation therapy; however, 50% of patients develop metastatic lesions and the five year survival rate is 70%.'"
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